ChemInform Abstract: TOTAL SYNTHESIS OF THE IONOPHORE ANTIBIOTIC X‐14547A (INDANOMYCIN)

Martin P. Edwards(Pfizer (United States)), David Williams(Cwm Taf University Health Board), Steven V. Ley(University of Cambridge), Simon Lister, Brian D. Palmer

Chemischer Informationsdienst

March 5, 1985

10.1002/chin.198509370

Cited by 0

Related Papers

Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis

|BMJ|2007|2.5k

Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)

|Journal of Medicinal Chemistry|2011|924

Targeting C-reactive protein for the treatment of cardiovascular disease

|Nature|2006|676

Discovery of (10 <i>R</i> )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- <i>2H</i> -8,4-(metheno)pyrazolo[4,3- <i>h</i> ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations

|Journal of Medicinal Chemistry|2014|587

Using the Golden Triangle to optimize clearance and oral absorption

|Bioorganic & Medicinal Chemistry Letters|2009|382